It could be useful to evaluate copeptin as a prognostic factor for other endpoints different from mortality (length of hospitalization, length of treatment with elevated costs, and long-term sepsis-induced organ damage) and as an independent prognostic index when compared with other variables related to risk (clinical scores, biohumoral values like lactate levels, and hemodynamic parameters). This evidence concerns the gene AVP and Sepsis.